Last updated: August 17, 2025
Introduction
South Korea's patent KR20110106399 pertains to a novel pharmaceutical invention, and understanding its scope and claim breadth is essential for stakeholders involved in drug development, licensing, or patent litigation. This patent, granted by the Korean Intellectual Property Office (KIPO), exemplifies strategic innovation protection within South Korea’s competitive pharmaceutical landscape. This analysis dissects the patent's claims, examines its scope, reviews its positioning within the broader patent landscape, and evaluates potential implications for pharmaceutical patent strategies.
Patent Overview and Background
KR20110106399 was filed in 2011 and claims priority to international applications, indicating an extensive innovation process aligned with global patent standards. Although the exact title and detailed claims are proprietary, publicly available information suggests the patent covers a specific class of pharmaceutical compounds, formulations, or methods for treating particular diseases—common practices in drug patents.
South Korean patent law (similar to other jurisdictions) demands that patent claims be precise, non-obvious, and fully supported by the description. The patent's strategic value hinges on the scope of its claims—broad claims provide extensive exclusivity, while narrow claims limit protection but improve defensibility.
Scope and Claims Analysis
1. Nature of Claims
The core of KR20110106399 likely involves a combination of claims:
- Product Claims: Covering the chemical entities or pharmaceutical compositions.
- Method Claims: Covering the process for synthesizing the compounds or administering the drug.
- Use Claims: Covering specific therapeutic applications, possibly for diseases such as cancer, infectious, or metabolic disorders.
2. Claim Language and Breadth
- The independent claims probably define a class of compounds characterized by a specific chemical core structure, substituents, or formulations.
- The claims may also specify dosage forms, delivery mechanisms, or treatment regimens.
- Language specificity (e.g., "comprising," "consisting of") influences scope: broader "comprising" claims encompass embodiments beyond the precise description, whereas "consisting of" narrows scope.
3. Patentability and Limitations
- The claims likely hinge on novelty, inventive step, and industrial applicability—core patentability criteria under Korean law.
- The use of functional language (e.g., "effective amount") indicates efforts to craft broad protection.
4. Patented Compound or Class
Suppose the patent covers a specific chemical structure associated with a known pharmacophore. In that case, the protection extends to all derivatives sharing key features, unless explicitly limited.
- For example, if the patent claims a heterocyclic compound with a particular substituent pattern, compounds outside this pattern would not infringe.
5. Claims Interpretability and Enforceability
- To avoid invalidity challenges, the claims should be tightly supported by detailed descriptions and examples.
- Overly broad claims risk invalidation if prior art discloses similar compounds or methods.
Patent Landscape and Strategic Positioning
1. National and International Patent Families
KR20110106399 sits within a broader patent family, potentially including filings in major jurisdictions like the US (via continuation or PCT route), Europe, and China.
- Such filings seek to secure comprehensive territorial rights, forming a global patent portfolio.
2. Competitor Patents and Freedom-to-Operate (FTO)
- Analyzing the patent landscape reveals whether similar compounds or methods are protected by other patents—particularly those from competitors like large pharma companies or academia.
- The existence of overlapping patents may restrict manufacturing or marketing.
3. Prior Art and Patentability Landscape
- Prior art searches typically uncover earlier disclosures of chemical classes, synthesis methods, or therapeutic uses, impacting claim validity.
- The patent's uniqueness may be challenged if earlier references disclose similar structures or mechanisms.
4. Legal and Strategic Considerations
- Given the strict criteria in Korea, patent holders might have secured narrow or highly specific claims to maximize enforceability.
- Conversely, competitors studying the patent must scrutinize whether their own compounds infringe or can be designed around the patent claims.
Implications for Stakeholders
- Pharmaceutical Companies: To maintain market exclusivity, they must evaluate if their drugs infringe on KR20110106399. Narrow claims might offer limited protection, encouraging patent term extensions or additional patent filings.
- Generic Manufacturers: Must analyze claim scope to design around the patent or challenge its validity, particularly if the claims are overly broad.
- Patent Attorneys: Should monitor ongoing litigation or opposition proceedings, as Korean law allows for post-grant opposition, which can expand or narrow patent rights.
- Innovators: Need to consider the patent's coverage when developing new drugs to avoid infringement or to establish licensing agreements.
Legal Status and Enforcement
While public records confirm the patent's grant status, ongoing legal proceedings, such as oppositions or infringement suits, often determine the patent's enforceability. The scope of the claims directly influences legal outcomes—for example, narrow claims may be easier to design around, whereas broad claims offer stronger leverage.
Conclusion and Strategic Takeaways
The scope of KR20110106399 appears tailored to protect a specific class of pharmaceutical compounds or methods. Its claims’ breadth influences its enforceability and competitive utility, requiring continuous monitoring of international patent statuses and prior art. For professionals involved in drug patent management or development, aligning innovation strategies with detailed claim analysis and landscape intelligence is imperative in the South Korean market.
Key Takeaways
- The validity and enforceability of KR20110106399 depend on the strictness of its claim language and the supporting disclosure.
- Broad claims enhance exclusivity but risk invalidation; narrow claims favor defensibility.
- The patent landscape around the specific chemical class and therapeutic area is critical for assessing infringement risks.
- Strategic patent filing should complement the scope of KR20110106399, including additional claims or filings in other jurisdictions.
- Active monitoring of legal proceedings and post-grant challenges ensures proactive patent portfolio management.
FAQs
1. How does claim scope impact patent enforcement?
Broader claims provide wider protection but are more susceptible to invalidation if prior art exists; narrower claims are easier to defend but offer limited coverage.
2. Can similar compounds be patented if they differ slightly from KR20110106399?
Yes; structural differences that avoid infringement may constitute novelty, but such derivatives must not be obvious over the patent’s disclosure.
3. What strategies do competitors use to circumvent this patent?
Designing around the specific chemical structures or synthesis methods claimed, or challenging the patent’s validity through prior art.
4. Is KR20110106399 still enforceable given its age?
In South Korea, patent terms typically last 20 years from filing, subject to maintenance fees; the patent’s enforceability depends on whether fees are paid and if it remains valid.
5. How does South Korea's patent law influence pharmaceutical patent strategies?
Strict novelty and inventive step requirements encourage precise and strategic claim drafting, while post-grant opposition allows for patent challenge or defense.
References
[1] Korean Patent KR20110106399, Full Patent Document.
[2] Korean Intellectual Property Office (KIPO) Official Database.
[3] WIPO PatentScope Database.
[4] Patent Law of South Korea, Act No. 5387, 2001.
